<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37084724</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-6711</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>Stem cell reports</Title><ISOAbbreviation>Stem Cell Reports</ISOAbbreviation></Journal><ArticleTitle>Human iPSC-derived neural progenitor cells secreting GDNF provide protection in rodent models of ALS and retinal degeneration.</ArticleTitle><Pagination><StartPage>1629</StartPage><EndPage>1642</EndPage><MedlinePgn>1629-1642</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.stemcr.2023.03.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-6711(23)00104-2</ELocationID><Abstract><AbstractText>Human induced pluripotent stem cells (iPSCs) are a renewable cell source that can be differentiated into neural progenitor cells (iNPCs) and transduced with glial cell line-derived neurotrophic factor (iNPC-GDNFs). The goal of the current study is to characterize iNPC-GDNFs and test their therapeutic potential and safety. Single-nuclei RNA-seq show iNPC-GDNFs express NPC markers. iNPC-GDNFs delivered into the subretinal space of the Royal College of Surgeons rodent model of retinal degeneration preserve photoreceptors and visual function. Additionally, iNPC-GDNF transplants in the spinal cord of SOD1<sup>G93A</sup> amyotrophic lateral sclerosis (ALS) rats preserve motor neurons. Finally, iNPC-GDNF transplants in the spinal cord of athymic nude rats survive and produce GDNF for 9&#xa0;months, with no signs of tumor formation or continual cell proliferation. iNPC-GDNFs survive long-term, are safe, and provide neuroprotection in models of both retinal degeneration and ALS, indicating their potential as a combined cell and gene therapy for various neurodegenerative diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laperle</LastName><ForeName>Alexander H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moser</LastName><ForeName>V Alexandra</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avalos</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fulton</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Stephany</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Veronica J</ForeName><Initials>VJ</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Shaughn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ritchie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawless</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roxas</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahin</LastName><ForeName>Saba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shelest</LastName><ForeName>Oksana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svendsen</LastName><ForeName>Soshana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shaomei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: shaomei.wang@cshs.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svendsen</LastName><ForeName>Clive N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: clive.svendsen@cshs.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stem Cell Reports</MedlineTA><NlmUniqueID>101611300</NlmUniqueID><ISSNLinking>2213-6711</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051100">Glial Cell Line-Derived Neurotrophic Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012377" MajorTopicYN="N">Rodentia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012162" MajorTopicYN="Y">Retinal Degeneration</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051100" MajorTopicYN="N">Glial Cell Line-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">CNS</Keyword><Keyword MajorTopicYN="N">Cell Therapy</Keyword><Keyword MajorTopicYN="N">GDNF</Keyword><Keyword MajorTopicYN="N">Human iPSC</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Retinitis Pigmentosa</Keyword><Keyword MajorTopicYN="N">Stem cell therapy</Keyword><Keyword MajorTopicYN="N">iPSC</Keyword></KeywordList><CoiStatement>Conflict of interests The authors declare no competing financial interests. Intellectual protection-patent &#x201c;Cortical Neural progenitor cells from iPSCs&#x201d; No. 62/924,523 was filed October 22, 2019.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>22</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37084724</ArticleId><ArticleId IdType="pmc">PMC10444557</ArticleId><ArticleId IdType="doi">10.1016/j.stemcr.2023.03.016</ArticleId><ArticleId IdType="pii">S2213-6711(23)00104-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akhtar A.A., Gowing G., Kobritz N., Savinoff S.E., Garcia L., Saxon D., Cho N., Kim G., Tom C.M., Park H., et al. Inducible expression of GDNF in transplanted iPSC-derived neural progenitor cells. Stem Cell Rep. 2018;10:1696&#x2013;1704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5989694</ArticleId><ArticleId IdType="pubmed">29706501</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres R.H., Horie N., Slikker W., Keren-Gill H., Zhan K., Sun G., Manley N.C., Pereira M.P., Sheikh L.A., McMillan E.L., et al. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain. 2011;134:1777&#x2013;1789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3102243</ArticleId><ArticleId IdType="pubmed">21616972</ArticleId></ArticleIdList></Reference><Reference><Citation>Ausubel L.J., Lopez P.M., Couture L.A. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications. Methods Mol. Biol. 2011;767:147&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">21822873</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloh R.H., Johnson J.P., Avalos P., Allred P., Svendsen S., Gowing G., Roxas K., Wu A., Donahue B., Osborne S., et al. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial. Nat. Med. 2022;28:1813&#x2013;1822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499868</ArticleId><ArticleId IdType="pubmed">36064599</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett R., Ornelas L., Yeager N., Mandefro B., Sahabian A., Lenaeus L., Targan S.R., Svendsen C.N., Sareen D. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines. Stem Cells Transl. Med. 2014;3:1429&#x2013;1434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4250214</ArticleId><ArticleId IdType="pubmed">25298370</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J.&#xa0;Neurotrauma. 1995;12:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">7783230</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrstock S., Ebert A., McHugh J., Vosberg S., Moore J., Schneider B., Capowski E., Hei D., Kordower J., Aebischer P., Svendsen C.N. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther. 2006;13:379&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">16355116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Capowski E.E., Schneider B.L., Ebert A.D., Seehus C.R., Szulc J., Zufferey R., Aebischer P., Svendsen C.N. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex&#xa0;vivo gene therapy. J.&#xa0;Neurosci. Methods. 2007;163:338&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">17397931</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009;27:275&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2756723</ArticleId><ArticleId IdType="pubmed">19252484</ArticleId></ArticleIdList></Reference><Reference><Citation>Das M.M., Avalos P., Suezaki P., Godoy M., Garcia L., Chang C.D., Vit J.-P., Shelley B., Gowing G., Svendsen C.N. Human neural progenitors differentiate into astrocytes and protect motor neurons in aging rats. Exp. Neurol. 2016;280:41&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">27032721</ArticleId></ArticleIdList></Reference><Reference><Citation>Draper J.S., Smith K., Gokhale P., Moore H.D., Maltby E., Johnson J., Meisner L., Zwaka T.P., Thomson J.A., Andrews P.W. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 2004;22:53&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">14661028</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert A.D., Shelley B.C., Hurley A.M., Onorati M., Castiglioni V., Patitucci T.N., Svendsen S.P., Mattis V.B., McGivern J.V., Schwab A.J., et al. EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs. Stem Cell Res. 2013;10:417&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786426</ArticleId><ArticleId IdType="pubmed">23474892</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamm D.M., Wang S., Lu B., Girman S., Holmes T., Bischoff N., Shearer R.L., Sauv&#xe9; Y., Capowski E., Svendsen C.N., Lund R.D. Protection of visual functions by human neural progenitors in a rat model of retinal disease. PLoS One. 2007;2:e338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1828619</ArticleId><ArticleId IdType="pubmed">17396165</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Caballero C., Lieppman B., Arranz-Romera A., Molina-Mart&#xed;nez I.T., Bravo-Osuna I., Young M., Baranov P., Herrero-Vanrell R. Photoreceptor preservation induced by intravitreal controlled delivery of GDNF and GDNF/melatonin in rhodopsin knockout mice. Mol. Vis. 2018;24:733&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6279195</ArticleId><ArticleId IdType="pubmed">30581280</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgievska B., Kirik D., Bj&#xf6;rklund A. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 2002;177:461&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">12429192</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg N.R.S., Marsh S.E., Ochaba J., Shelley B.C., Davtyan H., Thompson L.M., Steffan J.S., Svendsen C.N., Blurton-Jones M. Human neural progenitor transplantation rescues behavior and reduces &#x3b1;-synuclein in a transgenic model of dementia with lewy bodies. Stem Cells Transl. Med. 2017;6:1477&#x2013;1490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464354</ArticleId><ArticleId IdType="pubmed">28225193</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowing G., Shelley B., Staggenborg K., Hurley A., Avalos P., Victoroff J., Latter J., Garcia L., Svendsen C.N. Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats. Neuroreport. 2014;25:367&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969154</ArticleId><ArticleId IdType="pubmed">24284956</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada C., Harada T., Quah H.M.A., Maekawa F., Yoshida K., Ohno S., Wada K., Parada L.F., Tanaka K. Potential role of glial cell line-derived neurotrophic factor receptors in M&#xfc;ller glial cells during light-induced retinal degeneration. Neuroscience. 2003;122:229&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">14596863</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauck S.M., Kinkl N., Deeg C.A., Swiatek-de Lange M., Sch&#xf6;ffmann S., Ueffing M. GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells. Mol. Cell Biol. 2006;26:2746&#x2013;2757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1430306</ArticleId><ArticleId IdType="pubmed">16537917</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simmons L., Moffet B., Vandlen R.A., Simpson LC corrected to Simmons L., et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science. 1994;266:1062&#x2013;1064.</Citation><ArticleIdList><ArticleId IdType="pubmed">7973664</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovland D.N., Boyd R.B., Butt M.T., Engelhardt J.A., Moxness M.S., Ma M.H., Emery M.G., Ernst N.B., Reed R.P., Zeller J.R., et al. Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys. Toxicol. Pathol. 2007;35:1013&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">18098052</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulisz D. Amyotrophic lateral sclerosis: disease state overview. Am. J. Manag. Care. 2018;24:S320&#x2013;S326.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207670</ArticleId></ArticleIdList></Reference><Reference><Citation>Jomary C., Darrow R.M., Wong P., Organisciak D.T., Jones S.E. Expression of neurturin, glial cell line-derived neurotrophic factor, and their receptor components in light-induced retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2004;45:1240&#x2013;1246.</Citation><ArticleIdList><ArticleId IdType="pubmed">15037593</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M.K., Lu B., Saghizadeh M., Wang S. Gene expression changes in the retina following subretinal injection of human neural progenitor cells into a rodent model for retinal degeneration. Mol. Vis. 2016;22:472&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4872275</ArticleId><ArticleId IdType="pubmed">27217715</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein S.M., Behrstock S., McHugh J., Hoffmann K., Wallace K., Suzuki M., Aebischer P., Svendsen C.N. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum. Gene Ther. 2005;16:509&#x2013;521.</Citation><ArticleIdList><ArticleId IdType="pubmed">15871682</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore A.C., Rauck B., Dejea C., Pardo A.C., Rao M.S., Rothstein J.D., Maragakis N.J. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat. Neurosci. 2008;11:1294&#x2013;1301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2656686</ArticleId><ArticleId IdType="pubmed">18931666</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore A.C., O&#x2019;Donnell J., Kim A.S., Williams T., Tuteja A., Rao M.S., Kelley L.L., Campanelli J.T., Maragakis N.J. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One. 2011;6:e25968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3187829</ArticleId><ArticleId IdType="pubmed">21998733</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 1993;260:1130&#x2013;1132.</Citation><ArticleIdList><ArticleId IdType="pubmed">8493557</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Tang Y., L&#xfc; S., Zhou J., Du Z., Duan C., Li Z., Wang C. The tumourigenicity of iPS cells and their differentiated derivates. J.&#xa0;Cell Mol. Med. 2013;17:782&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3823182</ArticleId><ArticleId IdType="pubmed">23711115</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride J.L., Behrstock S.P., Chen E.-Y., Jakel R.J., Siegel I., Svendsen C.N., Kordower J.H. Human neural stem cell transplants improve motor function in a rat model of Huntington&#x2019;s disease. J.&#xa0;Comp. Neurol. 2004;475:211&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">15211462</ArticleId></ArticleIdList></Reference><Reference><Citation>McGill T.J., Lund R.D., Douglas R.M., Wang S., Lu B., Silver B.D., Secretan M.R., Arthur J.N., Prusky G.T. Syngeneic Schwann cell transplantation preserves vision in RCS rat without immunosuppression. Invest. Ophthalmol. Vis. Sci. 2007;48:1906&#x2013;1912.</Citation><ArticleIdList><ArticleId IdType="pubmed">17389527</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez I., Sanchez-Pernaute R., Cooper O., Vi&#xf1;uela A., Ferrari D., Bj&#xf6;rklund L., Dagher A., Isacson O. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson&#x2019;s disease. Brain. 2005;128:1498&#x2013;1510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2610438</ArticleId><ArticleId IdType="pubmed">15872020</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutt J.G., Burchiel K.J., Comella C.L., Jankovic J., Lang A.E., Laws E.R., Lozano A.M., Penn R.D., Simpson R.K., Stacy M., et al. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology. 2003;60:69&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">12525720</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano H. A combined stem-cell-gene therapy strategy for ALS. Nat. Med. 2022;28:1751&#x2013;1752.</Citation><ArticleIdList><ArticleId IdType="pubmed">36097225</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano H. Transplantation of neural progenitor cells into the human CNS. Trends Mol. Med. 2022;28:897&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pubmed">36182630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostenfeld T., Caldwell M.A., Prowse K.R., Linskens M.H., Jauniaux E., Svendsen C.N. Human neural precursor cells express low levels of telomerase in&#xa0;vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp. Neurol. 2000;164:215&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">10877932</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosati J., Ferrari D., Altieri F., Tardivo S., Ricciolini C., Fusilli C., Zalfa C., Profico D.C., Pinos F., Bernardini L., et al. Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies. Cell Death Dis. 2018;9:937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6141489</ArticleId><ArticleId IdType="pubmed">30224709</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandrock R.W., Wheatley W., Levinthal C., Lawson J., Hashimoto B., Rao M., Campanelli J.T. Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders. Regen. Med. 2010;5:381&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">20455649</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D., McMillan E., Ebert A.D., Shelley B.C., Johnson J.A., Meisner L.F., Svendsen C.N. Chromosome 7 and 19 trisomy in cultured human neural progenitor cells. PLoS One. 2009;4:e7630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2765070</ArticleId><ArticleId IdType="pubmed">19898616</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D., Gowing G., Sahabian A., Staggenborg K., Paradis R., Avalos P., Latter J., Ornelas L., Garcia L., Svendsen C.N. Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J.&#xa0;Comp. Neurol. 2014;522:2707&#x2013;2728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4070510</ArticleId><ArticleId IdType="pubmed">24610630</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelley B.C., Gowing G., Svendsen C.N. A cGMP-applicable expansion method for aggregates of human neural stem and progenitor cells derived from pluripotent stem cells or fetal brain tissue. J.&#xa0;Vis. Exp. 2014:51219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4195512</ArticleId><ArticleId IdType="pubmed">24962813</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M., McHugh J., Tork C., Shelley B., Klein S.M., Aebischer P., Svendsen C.N. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One. 2007;2:e689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1925150</ArticleId><ArticleId IdType="pubmed">17668067</ArticleId></ArticleIdList></Reference><Reference><Citation>Svendsen C.N. Back to the future: how human induced pluripotent stem cells will transform regenerative medicine. Hum. Mol. Genet. 2013;22:R32&#x2013;R38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3782070</ArticleId><ArticleId IdType="pubmed">23945396</ArticleId></ArticleIdList></Reference><Reference><Citation>Svendsen C.N., Caldwell M.A., Shen J., ter Borg M.G., Rosser A.E., Tyers P., Karmiol S., Dunnett S.B. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson&#x2019;s disease. Exp. Neurol. 1997;148:135&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">9398456</ArticleId></ArticleIdList></Reference><Reference><Citation>Svendsen C.N., ter Borg M.G., Armstrong R.J., Rosser A.E., Chandran S., Ostenfeld T., Caldwell M.A. A new method for the rapid and long term growth of human neural precursor cells. J.&#xa0;Neurosci. Methods. 1998;85:141&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">9874150</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen G.M., Gowing G., Latter J., Chen M., Vit J.-P., Staggenborg K., Avalos P., Alkaslasi M., Ferraiuolo L., Likhite S., et al. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. J.&#xa0;Neurosci. 2014;34:15587&#x2013;15600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4298650</ArticleId><ArticleId IdType="pubmed">25411487</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen G.M., Alkaslasi M., Vit J.P., Lawless G., Godoy M., Gowing G., Shelest O., Svendsen C.N. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1G93A ALS rat but has adverse side effects. Gene Ther. 2017;24:245&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404206</ArticleId><ArticleId IdType="pubmed">28276446</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen G.M., Avalos P., Ma A.A., Alkaslasi M., Cho N., Wyss L., Vit J.-P., Godoy M., Suezaki P., Shelest O., et al. Transplantation of neural progenitor cells expressing glial cell line-derived neurotrophic factor into the motor cortex as a strategy to treat amyotrophic lateral sclerosis. Stem Cell. 2018;36:1122&#x2013;1131.</Citation><ArticleIdList><ArticleId IdType="pubmed">29656478</ArticleId></ArticleIdList></Reference><Reference><Citation>Trupp M., Arenas E., Fainzilber M., Nilsson A.S., Sieber B.A., Grigoriou M., Kilkenny C., Salazar-Grueso E., Pachnis V., Arum&#xe4;e U. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature. 1996;381:785&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">8657281</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai Y., Lu B., Bakondi B., Girman S., Sahabian A., Sareen D., Svendsen C.N., Wang S. Human iPSC-derived neural progenitors preserve vision in an AMD-like model. Stem Cell. 2015;33:2537&#x2013;2549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5477659</ArticleId><ArticleId IdType="pubmed">25869002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Girman S., Lu B., Bischoff N., Holmes T., Shearer R., Wright L.S., Svendsen C.N., Gamm D.M., Lund R.D. Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 2008;49:3201&#x2013;3206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3055787</ArticleId><ArticleId IdType="pubmed">18579765</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright L.S., Prowse K.R., Wallace K., Linskens M.H.K., Svendsen C.N. Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in&#xa0;vitro. Exp. Cell Res. 2006;312:2107&#x2013;2120.</Citation><ArticleIdList><ArticleId IdType="pubmed">16631163</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell. 2020;27:523&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">33007237</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Cui W. Sox2, a key factor in the regulation of pluripotency and neural differentiation. World J. Stem Cells. 2014;6:305&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4131272</ArticleId><ArticleId IdType="pubmed">25126380</ArticleId></ArticleIdList></Reference><Reference><Citation>Zurn A.D., Baetge E.E., Hammang J.P., Tan S.A., Aebischer P. Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones. Neuroreport. 1994;6:113&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">7703397</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>